Prudential Securities

Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer

Retrieved on: 
Wednesday, February 28, 2024
CFO, Acquisition, Therapy, Accounting, Prudential Securities, FP, FP&A, Growth, Senior advisor, Stanford University, KPMG, Portola Pharmaceuticals, Alexion, University, Patient, Novartis, NASH, Chiron Corporation, UCLA, Fatty liver disease, Biology, Management

CONSHOHOCKEN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that Mardi C. Dier has been appointed Chief Financial Officer.

Key Points: 
  • CONSHOHOCKEN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that Mardi C. Dier has been appointed Chief Financial Officer.
  • She joined Ultragenyx from Portola Pharmaceuticals (acquired by Alexion), where she served as Chief Financial Officer for 14 years and, most recently, as Chief Business Officer and Chief Financial Officer.
  • Ms. Dier joined Madrigal on February 27, 2024, as an employee in a Senior Advisor role to the Company’s current Chief Financial Officer, Alex Howarth, and will move into the Chief Financial Officer role on March 11, 2024.
  • “As we welcome Mardi to the Madrigal team, I’d also like to thank our outgoing Chief Financial Officer Alex Howarth for his substantial contributions to the Company,” said Bill Sibold.

FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors

Retrieved on: 
Thursday, January 25, 2024
Software, Biotechnology, Health, Artificial Intelligence, Health Technology, Technology, Genetics, Health Insurance, Failure, Tulane University, Interim, Prudential Securities, FOXO, Business studies

FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced the appointment of Francis Colt deWolf to the Company’s Board of Directors.

Key Points: 
  • FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced the appointment of Francis Colt deWolf to the Company’s Board of Directors.
  • Prior to founding Colt Capital LLC, Mr. deWolf was a Senior Vice President at Oppenheimer and Company, where he oversaw a variety of financing activities.
  • “I could not be more delighted to welcome a capital markets executive of Francis’ stature to our board of directors,” stated Mark White, Interim CEO of FOXO Technologies.
  • The Company believes that the appointment of Mr. deWolf to the Board of Directors will resolve the issue of noncompliance.

Bitfarms Appoints Tracy Krumme as Senior Vice President, Head of Investor Relations

Retrieved on: 
Monday, January 8, 2024
Bitcoin, DXC Technology, Pullman Company, NCR Corporation, Thermo Fisher Scientific, Sandler, Microsoft, PPD, Partner, Sandler O'Neill and Partners, Research, Prudential Securities, Galderma, Growth, IPO, Senior, Cryptocurrency

TORONTO, Ontario and BROSSARD, Québec, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ: BITF//TSX: BITF), a global vertically integrated Bitcoin mining company, today announced that it has appointed Tracy Krumme as Senior Vice President, Head of Investor Relations.

Key Points: 
  • TORONTO, Ontario and BROSSARD, Québec, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ: BITF//TSX: BITF), a global vertically integrated Bitcoin mining company, today announced that it has appointed Tracy Krumme as Senior Vice President, Head of Investor Relations.
  • Ms. Krumme has more than 30 years of leadership experience in investor relations, financial communications, investment banking, and equity research.
  • “In addition to her extensive investor relations and capital markets experience, Tracy has an established reputation among the investment community.
  • I look forward to engaging with investors and analysts to foster relationships and effectively communicate Bitfarms’ compelling growth story.”

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer

Retrieved on: 
Monday, December 4, 2023
Dentistry, Marketing, Neurology, Jen, Bank, Citigroup, Biotechnology, Alnylam Pharmaceuticals, Research and development, Translational medicine, Scientist, Yale School of Medicine, Bank of America, MD, Doctor of Philosophy, Deutsche Bank, Prudential Securities, I&I, Inflammation, University, Bear Stearns, Growth, Rutgers University, Jennifer Fox, Patient, Head, Bristol Myers Squibb, Development, Yale New Haven Hospital, Pharmaceutical industry

“We are thrilled to welcome Tanya and Jen to our executive team,” said Lonnie Moulder, Founder and Chief Executive Officer of Zenas BioPharma.

Key Points: 
  • “We are thrilled to welcome Tanya and Jen to our executive team,” said Lonnie Moulder, Founder and Chief Executive Officer of Zenas BioPharma.
  • “Tanya is a deeply experienced physician-scientist leader and Jen is a seasoned healthcare finance and corporate development leader.
  • Prior to joining Zenas, Ms. Fox served as Chief Financial Officer at Nuvation Bio, a publicly traded biotechnology company.
  • Prior to joining Zenas, she served as Chief Development Officer and Head of Translational Medicine at Biohaven, a publicly traded biopharmaceutical company.

Limoneira Announces Change to Board of Directors

Retrieved on: 
Monday, December 18, 2023
Retail, Agriculture, Natural Resources, Food, Beverage, Diamond, Peter, College of Engineering (KNUST), Leonard Green & Partners, LGP, Investment, Cornell University, Manufacturers Hanover Corporation, Risk management, Marketing, Country, DLJ, Public Interest Declassification Board, Credit Suisse, Senior advisor, Retirement, Knowledge, Prudential Securities, Committee on Finance, Management

The Board of Directors of Limoneira Company (the “Company” or “Limoneira”) (Nasdaq: LMNR), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today announced the retirement of Elizabeth Blanchard Chess from the Company’s Board of Directors (the “Board”), effective January 1, 2024.

Key Points: 
  • The Board of Directors of Limoneira Company (the “Company” or “Limoneira”) (Nasdaq: LMNR), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today announced the retirement of Elizabeth Blanchard Chess from the Company’s Board of Directors (the “Board”), effective January 1, 2024.
  • Peter J. Nolan has been appointed to the Board, effective January 1, 2024, to fill the vacancy created by the retirement of Ms.
  • Following the appointment of Mr. Nolan, the Board will be comprised of seven directors, six of whom are independent.
  • Mr. Nolan currently serves on the Board of Directors of AerSale Holdings, Inc. Mr. Nolan serves as a trustee of the United States Olympic and Paralympic Foundation.

Moomoo Launched Mobile Money Podcast Hosted by VP of Strategy Justin Zacks

Retrieved on: 
Thursday, November 16, 2023
Moo, Zacks, UBS, Investment, University, Muumuu, Freedom, Apple, Prudential Securities, Business, IOS, Bloomberg News, Bachelor of Economics, Mobile phone, Science, Podcast, Economics

JERSEY CITY, N.J., Nov. 16, 2023 /PRNewswire/ -- An intuitive investment and trading platform moomoo , announces today that its Podcast Mobile Money by moomoo debuts on Apple iOS and Google Andriod platform.

Key Points: 
  • JERSEY CITY, N.J., Nov. 16, 2023 /PRNewswire/ -- An intuitive investment and trading platform moomoo , announces today that its Podcast Mobile Money by moomoo debuts on Apple iOS and Google Andriod platform.
  • The Podcast is hosted by Moomoo Technologies Inc.'s Vice President of Strategy Justin Zacks.
  • As the spokesperson of Moomoo Technologies, Zacks provides internal and external thought leadership about market dynamics and trading.
  • Please join Zacks and other moomoo community members by listening to the first episode and subscribing to the channel here:

McDermott Gall Wealth Management Joins Osaic

Retrieved on: 
Thursday, November 2, 2023
Morgan Stanley Wealth Management, Knowledge, Associate, Wells Fargo Advisors, Raymond James Financial, Economics, Family, Business development, Acquisition, University of Illinois Urbana-Champaign, GCG, Salomon Brothers, Oppenheimer Holdings, Partnership, University, Eye, Culture, Oppenheimer, Northern Illinois University, Champaign–Urbana metropolitan area, Prudential Securities, Financial adviser, PHOENIX

PHOENIX, Nov. 2, 2023 /PRNewswire/ -- Osaic, Inc. (Osaic), one of the nation's largest providers of wealth management strategies, announced the successful recruitment of McDermott Gall Wealth Management (McDermott Gall) of Chicago, IL. Founded by James McDermott and Matthew Gall, the former Raymond James & Associates practice joins the firm through GCG Advisory Partners (GCG).

Key Points: 
  • PHOENIX, Nov. 2, 2023 /PRNewswire/ -- Osaic, Inc. (Osaic), one of the nation's largest providers of wealth management strategies, announced the successful recruitment of McDermott Gall Wealth Management (McDermott Gall) of Chicago, IL.
  • Founded by James McDermott and Matthew Gall, the former Raymond James & Associates practice joins the firm through GCG Advisory Partners (GCG).
  • McDermott Gall employs a collaborative approach to assess, create, implement and manage highly customized strategies for clients.
  • "It's an honor to welcome McDermott Gall to Osaic," added Kristen Kimmell, Executive Vice President Business Development, Osaic.

NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer

Retrieved on: 
Monday, October 23, 2023
Apolipoprotein, Nomura Securities, Morgan Stanley, Neuroscience, NAMS, BMO Capital Markets, Biotechnology, CETP, Head, Research, Thomas Weisel Partners, The Wall Street Journal, Wall Street, Health, CFO, Therapy, Patient, Dyslipidemia, Cardiovascular disease, Prudential Securities, Pharmaceutical industry, Biology, New York University

Mr. Somaiya is an established healthcare executive with extensive financial and operational expertise, including over two decades of experience on Wall Street as a prominent biotechnology research analyst.

Key Points: 
  • Mr. Somaiya is an established healthcare executive with extensive financial and operational expertise, including over two decades of experience on Wall Street as a prominent biotechnology research analyst.
  • Ian is a proven leader, who possesses a breadth of industry experience, as well as deep relationships within the financial community,” said Michael Davidson, M.D., Chief Executive Officer of NewAmsterdam.
  • We look forward to his many contributions.”
    Mr. Somaiya joins NewAmsterdam Pharma with over twenty-five years’ experience in senior leadership roles in the biopharmaceutical industry.
  • Prior to joining TCR2, Mr. Somaiya was managing director and head of biotechnology research at BMO Capital Markets.

FTC, Department of Labor Partner to Protect Workers from Anticompetitive, Unfair, and Deceptive Practices

Retrieved on: 
Wednesday, September 27, 2023
Workforce, Department, Prudential Securities, Partnership, Employment, U.S. Department of Labor, Office of Inspector General, National Labor Relations Board, Federal Trade Commission, Commission, Policy, Uber, Ardagh Group, New York State Department of Labor, DOL, Social media, Competition, 7-Eleven, FTC, MOU, DaVita Inc., HomeAdvisor, Glass, Prudential, Research, Fraud, News, Financial adviser, Dietary supplement, Amazon, Burgerim
Key Points: 

FTC, Department of Labor Partner to Protect Workers from Anticompetitive, Unfair, and Deceptive Practices

Retrieved on: 
Wednesday, September 27, 2023
Workforce, Department, Prudential Securities, Partnership, Employment, U.S. Department of Labor, Office of Inspector General, National Labor Relations Board, Federal Trade Commission, Commission, Policy, Uber, Ardagh Group, New York State Department of Labor, DOL, Social media, Competition, 7-Eleven, FTC, MOU, DaVita Inc., HomeAdvisor, Glass, Prudential, Research, Fraud, News, Financial adviser, Dietary supplement, Amazon, Burgerim

“This agreement with the Department of Labor is part of our whole-of-government effort to protect workers from unlawful business practices,” said FTC Chair Lina M. Khan.

Key Points: 
  • “This agreement with the Department of Labor is part of our whole-of-government effort to protect workers from unlawful business practices,” said FTC Chair Lina M. Khan.
  • The agreement is part of a broader FTC initiative to use the agency’s full authority, including enforcement actions and Commission rulemaking, to protect workers.
  • The FTC has made it a priority to scrutinize mergers that may harm competition in U.S. labor markets.
  • The FTC has also prioritized cracking down on anticompetitive contract terms that put workers at a disadvantage.
  • The Commission is considering a proposed rule that would ban noncompete clauses in employment contracts, and has taken action to protect workers in several Commission orders.